Evidence map›Paper›PMID 28405025›Full record

ArticleNature2017

High-avidity IgA protects the intestine by enchaining growing bacteria.

Kathrin Moor, Médéric Diard, Mikael E Sellin, Boas Felmy, Sandra Y Wotzka, Albulena Toska, Erik Bakkeren, Markus Arnoldini, Florence Bansept, Alma Dal Co and 15 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 241 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
241citing papers in PubMed, 2 pooled it
30.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

241 citing papers in PubMed, 2 syntheses or guidelines pooled it, 404 citations in OpenAlex.

  1. Mucosal immunity and vaccine development.Signal transduction and targeted therapy · 2026
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Morphogenesis of bacterial colonies in liquid crystalline environments.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

181 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 5 institutions in 3 countries.

Kathrin MoorInstitute of Microbiology, ETH Zürich, 8093 Zürich, Switzerland.
Médéric DiardInstitute of Microbiology, ETH Zürich, 8093 Zürich, Switzerland.
Mikael E SellinInstitute of Microbiology, ETH Zürich, 8093 Zürich, Switzerland.
Boas FelmyInstitute of Microbiology, ETH Zürich, 8093 Zürich, Switzerland.
Sandra Y WotzkaInstitute of Microbiology, ETH Zürich, 8093 Zürich, Switzerland.
Albulena ToskaInstitute of Microbiology, ETH Zürich, 8093 Zürich, Switzerland.
Erik BakkerenInstitute of Microbiology, ETH Zürich, 8093 Zürich, Switzerland.
Markus ArnoldiniInstitute of Microbiology, ETH Zürich, 8093 Zürich, Switzerland.
Florence BanseptLaboratoire Jean Perrin (UMR 8237), CNRS - UPMC, 75005 Paris, France.
Alma Dal CoDepartment of Environmental Systems Science, ETH Zurich, Zürich, Switzerland.
Tom VöllerInstitute of Microbiology, ETH Zürich, 8093 Zürich, Switzerland.
Andrea MinolaHumabs BioMed SA, 6500 Bellinzona, Switzerland.
Blanca Fernandez-RodriguezInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona 6500, Switzerland.
Gloria AgaticHumabs BioMed SA, 6500 Bellinzona, Switzerland.
Sonia BarbieriInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona 6500, Switzerland.
Luca PiccoliInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona 6500, Switzerland.
Costanza CasiraghiInstitute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona 6500, Switzerland.
Davide CortiHumabs BioMed SA, 6500 Bellinzona, Switzerland.
Antonio LanzavecchiaInstitute of Microbiology, ETH Zürich, 8093 Zürich, Switzerland.
Roland R RegoesInstitute of Integrative Biology, ETH Zürich, 8092 Zürich, Switzerland.
Claude LoverdoLaboratoire Jean Perrin (UMR 8237), CNRS - UPMC, 75005 Paris, France.
Roman StockerInstitute of Environmental Engineering, Department of Civil, Environmental, and Geomatic Engineering, ETH Zürich, 8093 Zürich, Switzerland.
Douglas R BrumleyInstitute of Environmental Engineering, Department of Civil, Environmental, and Geomatic Engineering, ETH Zürich, 8093 Zürich, Switzerland.
Wolf-Dietrich HardtInstitute of Microbiology, ETH Zürich, 8093 Zürich, Switzerland.
Emma SlackInstitute of Microbiology, ETH Zürich, 8093 Zürich, Switzerland.
ETH Zurich · CHUniversità della Svizzera italiana · CHVir Biotechnology (Switzerland) · CHCentre National de la Recherche Scientifique · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccine-induced high-avidity IgA can protect against bacterial enteropathogens by directly neutralizing virulence factors or by poorly defined mechanisms that physically impede bacterial interactions with the gut tissues ('immune exclusion'). IgA-mediated cross-linking clumps bacteria in the gut lumen and is critical for protection against infection by non-typhoidal Salmonella enterica subspecies enterica serovar Typhimurium (S. Typhimurium). However, classical agglutination, which was thought to drive this process, is efficient only at high pathogen densities (≥10

Indexed as

Antibody AffinityAnimalsBacterial AdhesionBacterial VaccinesCecumColony Count, MicrobialConjugation, GeneticFemaleHumansImmunoglobulin AIntestinesMaleMicePlasmidsSalmonella InfectionsSalmonella typhimuriumBacterial VaccinesImmunoglobulin A

Identifiers

PMID28405025
OpenAlexW2606832973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.